Illumina
在场
是其中之一......
Illumina 是一家在股票代码 ILMN (US) 下上市的公司。
Illumina 拥有 3家子公司，其中包括 Grail、Illumina Ventures 和 Pacific Biosciences。
他们在：
高管
查看带有其 95 名主要高管的组织结构图
Illumina 搜索最多的简介
- Jacob Thaysen, Chief Executive Officer and Director
- Frances Arnold, Director
- Phil Schiller, Director
高管在Illumina变化
- Everett Cunningham已作为Chief Commercial Officer加入公司 (新闻发布的2024六月4号).
- Anna Richo已作为Director加入公司 (新闻发布的2024五月21号).
- Joydeep Goswami, Chief Financial Officer, Chief Strategy and Corporate Development Officer, 将于 20246月30 退休 (新闻发布的2024四月12号).
创建提醒
跟踪 Illumina 的高管变动
医疗设备
Illumina 拥有 992 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- ShiraTronics 刚刚宣布为 66 筹款数百万美元。 (公布2024十月23号).
- Johnson & Johnson 已收购 V-Wave (公布2024十月9号).
- Biolase Technology has filed for bankruptcy protection Biolase Technology (公布2024十月2号).
医疗设备 行业的其他推荐联系人
消息
Illumina 的最新新闻稿
- Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says
- Illumina To Webcast Upcoming Investor Conferences
- Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024
- Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting
- Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
- Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024
- Charles Dadswell to step down as General Counsel, Illumina initiates search for successor
- European Court of Justice rules in favor of Illumina in jurisdictional appeal
- FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
- Illumina announces strategy to accelerate value creation
- View more press releases Close
关于 Illumina 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Jacob Thaysen 
